International Stem Cell Corporation revenue

International Stem Cell Corporation revenue increased from $7.5 million in 2017 to $11.1 million in 2018, a 48.7% increase.

Annual Revenue ($)

International Stem Cell Corporation revenue was $11.09 m in FY, 2018

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$6.15 m$7.02 m$7.55 b$7.17 m$7.46 m$11.09 m
Growth14.15%107510.09%(99.91%)4.06%
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$1.67 m$1.65 m$1.59 m$1.96 m$1.62 m$1.82 b$2.14 b$1.62 b$1.92 b$1.94 b$2.01 b$1.76 m$1.85 b$2.63 m$5.67 m$3.20 m$2.22 m$2.32 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

International Stem Cell Corporation revenue breakdown by business segment: 30.3% from Cosmetic and 69.7% from Biomedical

International Stem Cell Corporation revenue breakdown by geographic segment: 85.1% from North America, 9.8% from Asia and 5.1% from Other

FY, 2016FY, 2017
Cosmetic2.85 m2.26 m
Biomedical4.32 m5.20 m
FY, 2016FY, 2017
North America6.06 m6.35 m
Europe362 k354 k
Other40 k27 k
Asia702 k728 k